AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - Reuters

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - Reuters

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study Reuters

June 6, 2026 at 06:50 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

United States

Tags

diabetes glucose monitor health health study medical technology non-insulin research

All Coverage

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxOLU1uNzJsNDVWUmN1UHVSalZqUGt3Z0lULXZpTkJjamVfVWQ1bU9qRmtCMzBHVkFTYVlqbXUwNHR5REd6T1lybmRsNV96T1hiQXdjWnV3X1ZNdnR6c2RUTEp2NGdueHJIOVFNVi1tamdOU2w2S1VfbFlPYzVfSlR5RW5aX0loMVBnbHJSZ2dTVGY5MUE5dzR2QWp2VTBvZVVZRXFVZHFrTW5mSlo3R1BXS0ZFUUJMUlRReGk1MGwwNXFrLWJ3WDRqSFhQb1JSelBmbnp5Q2Z6d29hWWZPVTlNU2toRQ?oc=5" target="_blank">Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Lilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com

Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com

September 29, 2026 at 10:15 PM

Novo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters

Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters

September 29, 2026 at 04:47 AM

Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study - Reuters

Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study Reuters

September 30, 2026 at 09:57 AM

US FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters

US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters

October 2, 2026 at 09:52 PM

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com

September 30, 2026 at 10:30 PM

US FDA approves AbbVie's drug for Parkinson's disease - reuters.com

US FDA approves AbbVie's drug for Parkinson's disease reuters.com

September 25, 2026 at 10:57 PM